Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications.
Al-Nesf MAY, Abdesselem HB, Bensmail I, Ibrahim S, Saeed WAH, Mohammed SSI, Razok A, Alhussain H, Aly RMA, Al Maslamani M, Ouararhni K, Khatib MY, Hssain AA, Omrani AS, Al-Kaabi S, Al Khal A, Al-Thani AA, Samsam W, Farooq A, Al-Suwaidi J, Al-Maadheed M, Al-Siddiqi HH, Butler AE, Decock JV, Mohamed-Ali V, Al-Ejeh F.
Al-Nesf MAY, et al. Among authors: al ejeh f, al suwaidi j, al maslamani m, al thani aa, al khal a, al maadheed m, al siddiqi hh, al kaabi s.
Nat Commun. 2022 Feb 17;13(1):946. doi: 10.1038/s41467-022-28639-4.
Nat Commun. 2022.
PMID: 35177642
Free PMC article.